Related Experiment Video
Updated: Mar 26, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
The association between metabolic complications and arterial hypertension in obese adolescents
Malgorzata Wojcik1, Jadwiga Malek1, Dominika Janus1
1Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, PAIP, Jagiellonian University Medical College, Krakow, Poland.
Objective:
There is increasing evidence for the contribution of obesity and its metabolic sequels in the development of arterial hypertension (AH).
Methods:
The casual blood pressure (CBP), 24hABPM, ambulatory arterial stiffness index (AASI) and symmetric (sAASI) ambulatory arterial stiffness index (both derived from a 24 h ABPM) and selected laboratory tests were performed in 130 obese (mean BMI SDS 4.2) adolescents at the mean age of 13.7 years.
Results:
AH was diagnosed in 36.2%, and in 33.8% patients on the basis of CBP and 24hABPM respectively. There were significant correlations between: CBPSBP insulin level (fasting r=0.19, p=0.03 and post glucose load r=0.18, p=0.04), HOMA-IR (r=0.18, p=0.04), and uric acid (UA) level (r=0.35, p<0.001); CBPDBP and UA level (r=0.23, p=0.01). There were significant correlations between 24hABPM parameters and cortisol secretion: dSBP and urinary free cortisol (r=0.3, p=0.03), nDBP and nMAP and cortisol rhythm (r=0.21, p=0.03). There a correlation between sAASI and creatinine level (r=0.29, p=0.002) and negative correlation between AASI and eGFR (r=-0.23, p=0.009).
Conclusions:
The increase of the CBP parameters is associated with insulin resistance and hyperuricemia, while the increase of ABPM results is proportional to the cortisol secretion in obese adolescents.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Hypertension II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients

